
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $966.7M | $1.2B | $1.6B | $1.2B | $1.1B | |
Revenue Growth (YoY) | -11.47% | 25.68% | 31.14% | -25.26% | -4.61% | |
Cost of Revenues | $587.8M | $773.2M | $1.2B | $803.3M | $717M | |
Gross Profit | $378.9M | $441.7M | $377.4M | $387.5M | $418.9M | |
Gross Profit Margin | 39.2% | 36.36% | 23.69% | 32.54% | 36.88% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $25.9M | $31M | $29.7M | $29.8M | $28.5M | |
Other Inc / (Exp) | $733K | $62K | $1.6M | $4.2M | $5.3M | |
Operating Expenses | $25.9M | $31M | $29.7M | $29.8M | $28.5M | |
Operating Income | $353M | $410.7M | $347.7M | $357.7M | $390.4M | |
Net Interest Expenses | $12M | $8.8M | $13.4M | $26.5M | $25.7M | |
EBT. Incl. Unusual Items | $341.7M | $401.9M | $335.8M | $335.4M | $370M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $564K | $549K | $1M | $813K | $835K | |
Net Income to Company | $341.1M | $401.4M | $334.8M | $334.6M | $369.2M | |
Minority Interest in Earnings | -$275M | -$318.8M | -$270.7M | -$280.3M | -$306.8M | |
Net Income to Common Excl Extra Items | $66.2M | $82.5M | $64.2M | $54.3M | $62.4M | |
Basic EPS (Cont. Ops) | $1.88 | $2.34 | $1.82 | $1.54 | $1.77 | |
Diluted EPS (Cont. Ops) | $1.88 | $2.34 | $1.82 | $1.54 | $1.77 | |
Weighted Average Basic Share | $35.2M | $35.2M | $35.2M | $35.2M | $35.2M | |
Weighted Average Diluted Share | $35.2M | $35.2M | $35.2M | $35.2M | $35.2M | |
EBITDA | $456.9M | $519.6M | $470.3M | $472.1M | $507.6M | |
EBIT | $353.7M | $410.8M | $349.3M | $361.9M | $395.7M | |
Revenue (Reported) | $966.7M | $1.2B | $1.6B | $1.2B | $1.1B | |
Operating Income (Reported) | $353M | $410.7M | $347.7M | $357.7M | $390.4M | |
Operating Income (Adjusted) | $353.7M | $410.8M | $349.3M | $361.9M | $395.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $268.2M | $362.4M | $307.7M | $284.7M | $237.6M | |
Revenue Growth (YoY) | 7.05% | 35.12% | -15.1% | -7.48% | -16.53% | |
Cost of Revenues | $180.5M | $271M | $201.6M | $182.5M | $183.5M | |
Gross Profit | $87.7M | $91.4M | $106.1M | $102.2M | $54.1M | |
Gross Profit Margin | 32.7% | 25.23% | 34.48% | 35.89% | 22.76% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.7M | $8.2M | $7.9M | $7.1M | $7.5M | |
Other Inc / (Exp) | $7K | -$25K | $820K | $1.3M | $1.3M | |
Operating Expenses | $8.7M | $8.2M | $7.9M | $7.1M | $7.5M | |
Operating Income | $79M | $83.2M | $98.2M | $95.1M | $46.6M | |
Net Interest Expenses | $2.2M | $2.2M | $7.3M | $6.6M | $5.5M | |
EBT. Incl. Unusual Items | $76.8M | $81M | $91.7M | $89.9M | $42.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $175K | $163K | $212K | $210K | $107K | |
Net Income to Company | $76.6M | $80.8M | $91.5M | $89.6M | $42.3M | |
Minority Interest in Earnings | -$61.5M | -$64.6M | -$76.6M | -$74.8M | -$37.4M | |
Net Income to Common Excl Extra Items | $15.1M | $16.2M | $14.9M | $14.8M | $4.9M | |
Basic EPS (Cont. Ops) | $0.43 | $0.46 | $0.42 | $0.42 | $0.14 | |
Diluted EPS (Cont. Ops) | $0.43 | $0.46 | $0.42 | $0.42 | $0.14 | |
Weighted Average Basic Share | $35.2M | $35.2M | $35.2M | $35.2M | $35.2M | |
Weighted Average Diluted Share | $35.2M | $35.2M | $35.2M | $35.2M | $35.2M | |
EBITDA | $106.6M | $114.5M | $125.6M | $124.4M | $75M | |
EBIT | $79M | $83.2M | $99M | $96.4M | $48M | |
Revenue (Reported) | $268.2M | $362.4M | $307.7M | $284.7M | $237.6M | |
Operating Income (Reported) | $79M | $83.2M | $98.2M | $95.1M | $46.6M | |
Operating Income (Adjusted) | $79M | $83.2M | $99M | $96.4M | $48M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $984.3M | $1.3B | $1.5B | $1.2B | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $621.3M | $863.6M | $1.1B | $784.2M | $718M | |
Gross Profit | $363M | $445.4M | $392M | $383.6M | $370.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $28.4M | $30.6M | $29.4M | $28.9M | $28.9M | |
Other Inc / (Exp) | $155K | $30K | $2.4M | $4.7M | $5.3M | |
Operating Expenses | $28.4M | $30.6M | $29.4M | $28.9M | $28.9M | |
Operating Income | $334.7M | $414.9M | $362.6M | $354.7M | $341.9M | |
Net Interest Expenses | $10.3M | $8.8M | $18.5M | $25.8M | $24.7M | |
EBT. Incl. Unusual Items | $324.5M | $406.1M | $346.5M | $333.6M | $322.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $522K | $537K | $1.1M | $811K | $732K | |
Net Income to Company | $324M | $405.6M | $345.5M | $332.8M | $321.8M | |
Minority Interest in Earnings | -$260.4M | -$322M | -$282.6M | -$278.6M | -$269.3M | |
Net Income to Common Excl Extra Items | $63.6M | $83.6M | $62.9M | $54.2M | $52.5M | |
Basic EPS (Cont. Ops) | $1.82 | $2.37 | $1.79 | $1.54 | $1.49 | |
Diluted EPS (Cont. Ops) | $1.82 | $2.37 | $1.79 | $1.54 | $1.49 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $439.5M | $527.5M | $481.5M | $471M | $458.2M | |
EBIT | $334.8M | $414.9M | $365M | $359.4M | $347.2M | |
Revenue (Reported) | $984.3M | $1.3B | $1.5B | $1.2B | $1.1B | |
Operating Income (Reported) | $334.7M | $414.9M | $362.6M | $354.7M | $341.9M | |
Operating Income (Adjusted) | $334.8M | $414.9M | $365M | $359.4M | $347.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $268.2M | $362.4M | $307.7M | $284.7M | $237.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $180.5M | $271M | $201.6M | $182.5M | $183.5M | |
Gross Profit | $87.7M | $91.4M | $106.1M | $102.2M | $54.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.7M | $8.2M | $7.9M | $7.1M | $7.5M | |
Other Inc / (Exp) | $7K | -$25K | $820K | $1.3M | $1.3M | |
Operating Expenses | $8.7M | $8.2M | $7.9M | $7.1M | $7.5M | |
Operating Income | $79M | $83.2M | $98.2M | $95.1M | $46.6M | |
Net Interest Expenses | $2.2M | $2.2M | $7.3M | $6.6M | $5.5M | |
EBT. Incl. Unusual Items | $76.8M | $81M | $91.7M | $89.9M | $42.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $175K | $163K | $212K | $210K | $107K | |
Net Income to Company | $76.6M | $80.8M | $91.5M | $89.6M | $42.3M | |
Minority Interest in Earnings | -$61.5M | -$64.6M | -$76.6M | -$74.8M | -$37.4M | |
Net Income to Common Excl Extra Items | $15.1M | $16.2M | $14.9M | $14.8M | $4.9M | |
Basic EPS (Cont. Ops) | $0.43 | $0.46 | $0.42 | $0.42 | $0.14 | |
Diluted EPS (Cont. Ops) | $0.43 | $0.46 | $0.42 | $0.42 | $0.14 | |
Weighted Average Basic Share | $35.2M | $35.2M | $35.2M | $35.2M | $35.2M | |
Weighted Average Diluted Share | $35.2M | $35.2M | $35.2M | $35.2M | $35.2M | |
EBITDA | $106.6M | $114.5M | $125.6M | $124.4M | $75M | |
EBIT | $79M | $83.2M | $99M | $96.4M | $48M | |
Revenue (Reported) | $268.2M | $362.4M | $307.7M | $284.7M | $237.6M | |
Operating Income (Reported) | $79M | $83.2M | $98.2M | $95.1M | $46.6M | |
Operating Income (Adjusted) | $79M | $83.2M | $99M | $96.4M | $48M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $17.2M | $17.1M | $64.8M | $58.6M | $58.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $11M | $5.8M | $18.5M | $15.3M | $11.6M | |
Inventory | $3.5M | $8.9M | $4.7M | $4.4M | $4.1M | |
Prepaid Expenses | $392K | -- | -- | -- | -- | |
Other Current Assets | -- | $396K | $305K | $442K | $444K | |
Total Current Assets | $263.3M | $281.2M | $245.8M | $226.2M | $240.9M | |
Property Plant And Equipment | $1.1B | $1B | $990.2M | $943.8M | $903.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $4.4M | $3.2M | $2.5M | $7.8M | $8.1M | |
Total Assets | $1.4B | $1.5B | $1.4B | $1.3B | $1.3B | |
Accounts Payable | $21M | $45.9M | $49.4M | $31.4M | $38.5M | |
Accrued Expenses | $18.8M | $60.9M | $10.9M | $25M | $16.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $4M | $5.5M | -- | |
Total Current Liabilities | $39.8M | $106.8M | $66.9M | $56.3M | $55.4M | |
Long-Term Debt | $399.7M | $399.7M | $399.7M | $399.7M | $399.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $441.4M | $508M | $468.3M | $460.6M | $458.6M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $277.4M | $294M | $291.9M | $279.9M | $276.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $637.7M | $678.7M | $611.8M | $576.3M | $553.2M | |
Total Equity | $915.1M | $972.7M | $903.7M | $856.3M | $829.3M | |
Total Liabilities and Equity | $1.4B | $1.5B | $1.4B | $1.3B | $1.3B | |
Cash and Short Terms | $17.2M | $17.1M | $64.8M | $58.6M | $58.3M | |
Total Debt | $399.7M | $399.7M | $399.7M | $399.7M | $399.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $17.3M | $19.2M | $104.6M | $55.8M | $49.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $19.7M | $26.4M | $68.6M | $23.9M | $13M | |
Inventory | $3.2M | $7.9M | $5.5M | $4.9M | $2.7M | |
Prepaid Expenses | $217K | $238K | -- | -- | -- | |
Other Current Assets | -- | -- | $153K | $257K | $201K | |
Total Current Assets | $278.6M | $274.7M | $232.4M | $224.3M | $225.2M | |
Property Plant And Equipment | $1B | $1B | $977.5M | $926.8M | $903.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $33.5M | $143.3M | $127M | $138.1M | $236.9M | |
Total Assets | $1.4B | $1.5B | $1.3B | $1.3B | $1.4B | |
Accounts Payable | $24.5M | $55.6M | $30.4M | $23.3M | $101.5M | |
Accrued Expenses | $18M | $21.4M | $21.1M | $19.8M | $63.3M | |
Current Portion Of Long-Term Debt | -- | $377.1M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $42.6M | $454M | $51.5M | $43.1M | $164.8M | |
Long-Term Debt | $399.7M | $22.6M | $399.7M | $399.7M | $399.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $444M | $478.1M | $452.8M | $446.8M | $568.2M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $637.2M | $682.7M | $599.7M | $570.1M | $538.6M | |
Total Equity | $913.1M | $976.2M | $889.9M | $848.2M | $803.1M | |
Total Liabilities and Equity | $1.4B | $1.5B | $1.3B | $1.3B | $1.4B | |
Cash and Short Terms | $17.3M | $19.2M | $104.6M | $55.8M | $49.6M | |
Total Debt | $399.7M | $399.7M | $399.7M | $399.7M | $399.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $341.1M | $401.4M | $334.8M | $334.6M | $369.2M | |
Depreciation & Amoritzation | $103.2M | $108.8M | $121.1M | $110.2M | $111.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$72.9M | -$26.3M | $59.8M | $28.7M | $33M | |
Change in Inventories | -$990K | -$5.4M | $4.2M | $283K | $374K | |
Cash From Operations | $373.4M | $408.4M | $463.7M | $452M | $485M | |
Capital Expenditures | $37M | $81.2M | $54.1M | $46.8M | $49M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $2M | -$64.3M | -$12M | -$75.9M | -$89M | |
Dividends Paid (Ex Special Dividend) | -$66.4M | -$66.4M | -$66.4M | -$66.4M | -$66.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $32M | $209.3M | $219M | |
Long-Term Debt Repaid | -- | -- | -$32M | -$209.3M | -$219M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$311.8M | -$277.9M | -$337.6M | -$315.8M | -$329.9M | |
Cash From Financing | -$378.2M | -$344.2M | -$404M | -$382.2M | -$396.3M | |
Beginning Cash (CF) | $19.9M | $17.2M | $17.1M | $64.8M | $58.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2.8M | -$97K | $47.7M | -$6.2M | -$303K | |
Ending Cash (CF) | $17.2M | $17.1M | $64.8M | $58.6M | $58.3M | |
Levered Free Cash Flow | $336.4M | $327.3M | $409.6M | $405.2M | $436M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $76.6M | $80.8M | $91.5M | $89.6M | $42.3M | |
Depreciation & Amoritzation | $27.5M | $31.3M | $26.6M | $28M | $27.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $52.2M | $35.1M | $20.7M | -$5M | -$2.7M | |
Change in Inventories | $303K | $1M | -$751K | -$428K | $1.3M | |
Cash From Operations | $155.4M | $104.8M | $144.9M | $104.6M | $45.8M | |
Capital Expenditures | $12.7M | $20.3M | $12.7M | $9.8M | $16M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$76.6M | -$25.3M | $228K | -$9.8M | $14M | |
Dividends Paid (Ex Special Dividend) | -$16.6M | -$16.6M | -$16.6M | -$16.6M | -$16.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $39M | $54M | $54M | |
Long-Term Debt Repaid | -- | -- | -$39M | -$54M | -$54M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$62.1M | -$60.7M | -$88.7M | -$81M | -$51.9M | |
Cash From Financing | -$78.7M | -$77.3M | -$105.3M | -$97.7M | -$68.5M | |
Beginning Cash (CF) | $17.2M | $17.1M | $64.8M | $58.6M | $58.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $135K | $2.2M | $39.8M | -$2.9M | -$8.7M | |
Ending Cash (CF) | $17.3M | $19.2M | $104.6M | $55.8M | $49.6M | |
Levered Free Cash Flow | $142.7M | $84.5M | $132.2M | $94.8M | $29.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $324M | $405.6M | $345.5M | $332.8M | $321.8M | |
Depreciation & Amoritzation | $104.7M | $112.6M | $116.4M | $111.6M | $111M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$8.4M | -$43.4M | $45.3M | $3M | $35.3M | |
Change in Inventories | -$1.2M | -$4.7M | $2.4M | $606K | $2.1M | |
Cash From Operations | $417.8M | $357.8M | $503.8M | $411.7M | $426.2M | |
Capital Expenditures | $37.7M | $88.8M | $46.4M | $43.9M | $55.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$63.6M | -$13M | $13.6M | -$85.9M | -$65.2M | |
Dividends Paid (Ex Special Dividend) | -$66.4M | -$66.4M | -$66.4M | -$66.4M | -$66.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $71M | $224.3M | $219M | |
Long-Term Debt Repaid | -- | -- | -$71M | -$224.3M | -$219M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$294.7M | -$276.5M | -$365.6M | -$308.2M | -$300.8M | |
Cash From Financing | -$361M | -$342.9M | -$432M | -$374.6M | -$367.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$6.8M | $1.9M | $85.4M | -$48.8M | -$6.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $380.1M | $269.1M | $457.4M | $367.8M | $371.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $76.6M | $80.8M | $91.5M | $89.6M | $42.3M | |
Depreciation & Amoritzation | $27.5M | $31.3M | $26.6M | $28M | $27.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $52.2M | $35.1M | $20.7M | -$5M | -$2.7M | |
Change in Inventories | $303K | $1M | -$751K | -$428K | $1.3M | |
Cash From Operations | $155.4M | $104.8M | $144.9M | $104.6M | $45.8M | |
Capital Expenditures | $12.7M | $20.3M | $12.7M | $9.8M | $16M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$76.6M | -$25.3M | $228K | -$9.8M | $14M | |
Dividends Paid (Ex Special Dividend) | -$16.6M | -$16.6M | -$16.6M | -$16.6M | -$16.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $39M | $54M | $54M | |
Long-Term Debt Repaid | -- | -- | -$39M | -$54M | -$54M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$62.1M | -$60.7M | -$88.7M | -$81M | -$51.9M | |
Cash From Financing | -$78.7M | -$77.3M | -$105.3M | -$97.7M | -$68.5M | |
Beginning Cash (CF) | $17.2M | $17.1M | $64.8M | $58.6M | $58.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $135K | $2.2M | $39.8M | -$2.9M | -$8.7M | |
Ending Cash (CF) | $17.3M | $19.2M | $104.6M | $55.8M | $49.6M | |
Levered Free Cash Flow | $142.7M | $84.5M | $132.2M | $94.8M | $29.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.